Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $5.98 USD
Change Today +0.04 / 0.67%
Volume 195.0K
NEO On Other Exchanges
As of 8:10 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven C. Jones

Chief Compliance Officer, Executive Vice President of Finance, Director of Investor Relations, Director and Chairman of Compliance Committee,Neogenomics Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 3 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Steven C. Jones, also known as Steve, has been Executive Vice President of Finance at NeoGenomics Inc. since November 30, 2009. and has been its Chief Compliance Officer since February 07, 2013. Mr. Jones serves as an Executive Vice President of Finance at Neogenomics Laboratories, Inc., and also serves as its Director of Investor Relations. He serves as the Managing Director of Medical Venture Partners LLC. Mr. Jones has also been the President and Managing Director ...

Read Full Background

Corporate Headquarters*

12701 Commonwealth Drive
Fort Myers, Florida 33913

United States

Phone: 239-768-0600
Fax: 239-690-4237

Board Members Memberships*

Chief Compliance Officer, Executive Vice President of Finance, Director of Investor Relations, Director and Chairman of Compliance Committee
Executive Vice President of Finance, Director of Investor Relations and Director


BS 1985
University of Michigan
MBA 1991
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$177,500

Stock Options*

All Other Compensation$257,500

Total Compensation*

Total Annual Cash Compensation$440,821
Total Short Term Compensation$177,500
Other Long Term Compensation$257,500
Total Calculated Compensation$440,821
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEO:US $5.98 USD +0.04


Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
Kimberly J. Popovits Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
Michael J. Pellini M.D., MBAChief Executive Officer and Director
Foundation Medicine, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGENOMICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at